ATP-citrate lyase is essential for macrophage inflammatory response

Biochemical and Biophysical Research Communications

Volumn 440, Issue 1, 2013, Pages 105-111

  Infantino, Vittoria ^a   Iacobazzi, Vito ^b,c   Palmieri, Ferdinando ^b,c   Menga, Alessio ^b  

^a UNIVERSITY OF BASILICATA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c CNR   (Italy)

Author keywords

ATP citrate lyase; Immunometabolism; Inflammation; Nitric oxide; Prostaglandin E2; Reactive oxygen species

Indexed keywords

ADENOSINE TRIPHOSPHATE CITRATE LYASE; GAMMA INTERFERON; HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; STAT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ENERGY; CELL MEMBRANE; CELL VIABILITY; CONTROLLED STUDY; ENERGY METABOLISM; GENE ACTIVATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; MACROPHAGE ACTIVATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; UPREGULATION;

ATP-CITRATE LYASE; IMMUNOMETABOLISM; INFLAMMATION; NITRIC OXIDE; PROSTAGLANDIN E2; REACTIVE OXYGEN SPECIES;

ADULT; ATP CITRATE (PRO-S)-LYASE; CELL LINE; CELLS, CULTURED; DINOPROSTONE; HUMANS; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; MACROPHAGE ACTIVATION; MACROPHAGES; NF-KAPPA B; NITRIC OXIDE; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84885388000     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.09.037     Document Type: Article

References (26)

1. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
2. Barton G.M. A calculated response: control of inflammation by the innate immune system. J. Clin. Invest. 2008, 118:413-420.
3. Watson J.A., Fang M., Lowenstein J.M. Tricarballylate and hydroxycitrate: substrate and inhibitor of ATP: citrate oxaloacetate lyase. Arch. Biochem. Biophys. 1969, 135:209-217.
4. Iacobazzi V., Infantino V., Palmieri F. Epigenetic mechanisms and Sp1 regulate mitochondrial citrate carrier gene expression. Biochem. Biophys. Res. Commun. 2008, 376:15-20.
5. Wellen K.E., Hatzivassiliou G., Sachdeva U.M., Bui T.V., Cross J.R., Thompson C.B. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 2009, 324:1076-1080.
6. Hatzivassiliou G., Zhao F., Bauer D.E., Andreadis C., Shaw A.N., Dhanak D., Hingorani S.R., Tuveson D.A., Thompson C.B. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 2005, 8:311-321.
7. Infantino V., Convertini P., Cucci L., Panaro M.A., Di Noia M.A., Calvello R., Palmieri F., Iacobazzi V. The mitochondrial citrate carrier: a new player in inflammation. Biochem. J. 2011, 438:433-436.
8. Menga A., Infantino V., Iacobazzi F., Convertini P., Palmieri F., Iacobazzi V. Insight into mechanism of in vitro insulin secretion increase induced by antipsychotic clozapine: role of FOXA1 and mitochondrial citrate carrier. Eur. Neuropsychopharmacol. 2013, 23:978-987.
9. Iacobazzi V., Infantino V., Convertini P., Vozza A., Agrimi G., Palmieri F. Transcription of the mitochondrial citrate carrier gene: identification of a silencer and its binding protein ZNF224. Biochem. Biophys. Res. Commun. 2009, 386:186-191.
10. Infantino V., Convertini P., Iacobazzi F., Pisano I., Scarcia P., Iacobazzi V. Identification of a novel Sp1 splice variant as a strong transcriptional activator. Biochem. Biophys. Res. Commun. 2011, 412:86-91.
11. Infantino V., Iacobazzi V., De Santis F., Mastrapasqua M., Palmieri F. Transcription of the mitochondrial citrate carrier gene: role of SREBP-1, upregulation by insulin and downregulation by PUFA. Biochem. Biophys. Res. Commun. 2007, 356:249-254.
12. Sala R., Rotoli B.M., Colla E., Visigalli R., Parolari A., Bussolati O., Gazzola G.C., Dall'Asta V. Two-way arginine transport in human endothelial cells: TNF-alpha stimulation is restricted to system y(+). Am. J. Physiol. Cell Physiol. 2002, 282:C134-143.
13. Wang H., Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med. 1999, 27:612-616.
14. O'Neill L.A., Hardie D.G. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 2013, 493:346-355.
15. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511.
16. Kovarik P., Stoiber D., Novy M., Decker T. Stat1 combines signals derived from IFN-gamma and LPS receptors during macrophage activation. EMBO J. 1998, 17:3660-3668.
17. Abate A., Schroder H. Protease inhibitors protect macrophages from lipopolysaccharide-induced cytotoxicity: possible role for NF-kappaB. Life Sci. 1998, 62:1081-1088.
18. Nelson E.A., Walker S.R., Kepich A., Gashin L.B., Hideshima T., Ikeda H., Chauhan D., Anderson K.C., Frank D.A. Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3. Blood 2008, 112:5095-5102.
19. Beg A.A., Finco T.S., Nantermet P.V., Baldwin A.S. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol. Cell Biol. 1993, 13:3301-3310.
20. Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004, 75:163-189.
21. Ki S.W., Ishigami K., Kitahara T., Kasahara K., Yoshida M., Horinouchi S. Radicicol binds and inhibits mammalian ATP citrate lyase. J. Biol. Chem. 2000, 275:39231-39236.
22. Abramson H.N. The lipogenesis pathway as a cancer target. J. Med. Chem. 2011, 54:5615-5638.
23. Park J.Y., Pillinger M.H., Abramson S.B. Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin. Immunol. 2006, 119:229-240.
24. Babior B.M. NADPH oxidase. Curr. Opin. Immunol. 2004, 16:42-47.
25. Lee I.T., Yang C.M. Role of NADPH oxidase/ROS in pro-inflammatory mediators-induced airway and pulmonary diseases. Biochem. Pharmacol. 2012, 84:581-590.
26. Arnoult D., Soares F., Tattoli I., Girardin S.E. Mitochondria in innate immunity. EMBO Rep. 2011, 12:901-910.